Renal function affects absorbed dose to the kidneys and haematological toxicity during 177Lu-DOTATATE treatment

References

Page 1

	Year	Citations
The definition, classification, and prognosis of chronic kidney disease: a KDIGO Controversies Conference report Andrew S. Levey, Paul E. de Jong, Josef Coresh, Kidney International HemodialysisUrologyRenal DiseaseRenal FunctionKidney Failure	2010	2.3K
Treatment With the Radiolabeled Somatostatin Analog [ <sup>177</sup> Lu-DOTA <sup>0</sup> ,Tyr <sup>3</sup> ]Octreotate: Toxicity, Efficacy, and Survival Dik J. Kwekkeboom, Wouter W. de Herder, Boen L.R. Kam, Journal of Clinical Oncology	2008	1.4K
[177Lu-DOTA0,Tyr3]octreotate: comparison with [111In-DTPA0]octreotide in patients Dik J. Kwekkeboom, Willem H. Bakker, P.P.M. Kooij, European Journal of Nuclear Medicine and Molecular Imaging Clinical TranslationMedicinePathologyMolecular DiagnosticsMolecular Medicine	2001	468
Long-term evaluation of renal toxicity after peptide receptor radionuclide therapy with 90Y-DOTATOC and 177Lu-DOTATATE: the role of associated risk factors Lisa Bodei, Marta Cremonesi, Mahila Ferrari, European Journal of Nuclear Medicine and Molecular Imaging UrologyRenal FunctionMedicineRadionuclide TherapyLong-term Evaluation	2008	413
Peptide receptor radionuclide therapy with 177Lu-DOTATATE: the IEO phase I-II study Lisa Bodei, Marta Cremonesi, Chiara Maria Grana, European Journal of Nuclear Medicine and Molecular Imaging EngineeringMedicineRadionuclide TherapyTheranosticsNeuropeptide Receptor	2011	411
Phase II/III Study of Doxorubicin With Fluorouracil Compared With Streptozocin With Fluorouracil or Dacarbazine in the Treatment of Advanced Carcinoid Tumors: Eastern Cooperative Oncology Group Study E1281 Weijing Sun, Stuart R. Lipsitz, Paul J. Catalano, Journal of Clinical Oncology	2005	355
Long-term follow-up of renal function after peptide receptor radiation therapy with (90)Y-DOTA(0),Tyr(3)-octreotide and (177)Lu-DOTA(0), Tyr(3)-octreotate. Roelf Valkema, Stanislas Pauwels, Larry K. Kvols, PubMed	2005	334
PREFACE Keith F. Eckerman, Akira Endo Annals of the ICRP Health SciencesPhysical DataRadioactive ContaminationMass SpectrometryRadiation Dose	2008	308
Individualized Dosimetry of Kidney and Bone Marrow in Patients Undergoing <sup>177</sup>Lu-DOTA-Octreotate Treatment Mattias Sandström, Ulrike Garske‐Román, Silvia Johansson, Journal of Nuclear Medicine	2012	275
<sup>177</sup>Lu‐[DOTA0,Tyr3] octreotate therapy in patients with disseminated neuroendocrine tumors: Analysis of dosimetry with impact on future therapeutic strategy Michael Garkavij, Mattias Nickel, Katarina Sjögreen Gleisner, Cancer	2010	208

Page 1